Optimising maternal-fetal outcomes in preterm labour: a decision analysis

被引:21
作者
Macones, GA
Bader, TJ
Asch, DA
机构
[1] Univ Penn, Sch Med, Dept Obstet & Gynaecol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[3] Vet Affairs Med Ctr, Philadelphia, PA USA
[4] Univ Penn, Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA
来源
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 1998年 / 105卷 / 05期
关键词
D O I
10.1111/j.1471-0528.1998.tb10156.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To compare, using decision analytic techniques, maternal and fetal risk and benefits of three strategies for the management of preterm labour after 32 weeks. These strategies are empiric tocolysis, no tocolysis, or amniocentesis for fetal maturity testing. Data Sources Published medical literature provided the probabilities, including those for tocolysis efficacy, maternal and neonatal outcomes, and, steroid efficacy. Data Synthesis Separate decision trees were created for hypothetical cohorts of patients presenting with preterm labour at 32, 34, and 36 weeks of gestation to compare strategies. The primary outcome was the total number of expected adverse maternal and neonatal events for each strategy at each gestational age. Results At 32 weeks tocolysis yielded the lowest total number of adverse maternal and neonatal events. At 34 weeks, both tocolysis and no tocolysis yielded similar overall outcomes. At 36 weeks most clinical outcomes were good regardless of strategy. Conclusions This analysis supports the empiric use of tocolytics at 32 weeks. At 34 weeks, either tocolysis or no tocolysis appear to be reasonable alternatives. At 36 weeks no tocolysis is probably preferred. This analysis also suggests that amniocentesis should not be employed in the management of preterm labour at these gestational ages.
引用
收藏
页码:541 / 550
页数:10
相关论文
共 52 条
[1]  
ARMER T L, 1991, Obstetrical and Gynecological Survey, V46, P589, DOI 10.1097/00006254-199109000-00002
[2]  
BARDEN TP, 1980, OBSTET GYNECOL, V56, P1
[3]   A COMPARISON OF RITODRINE, TERBUTALINE, AND MAGNESIUM-SULFATE FOR THE SUPPRESSION OF PRETERM LABOR [J].
BEALL, MH ;
EDGAR, BW ;
PAUL, RH ;
SMITHWALLACE, T .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1985, 153 (08) :854-859
[4]  
BENEDETTI TJ, 1983, AM J OBSTET GYNECOL, V145, P1
[5]   A DOUBLE-BLIND-STUDY COMPARING RITODRINE AND TERBUTALINE IN THE TREATMENT OF PRETERM LABOR [J].
CARITIS, SN ;
TOIG, G ;
HEDDINGER, LA ;
ASHMEAD, G .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1984, 150 (01) :7-14
[6]  
Collett D., 1994, Modelling Survival Data in Medical Research
[7]  
CONNOR MC, 1979, BRIT J OBSTET GYNAEC, V86, P706
[8]   A MULTICENTER STUDY OF PRETERM BIRTH-WEIGHT AND GESTATIONAL-AGE SPECIFIC NEONATAL-MORTALITY [J].
COPPER, RL ;
GOLDENBERG, RL ;
CREASY, RK ;
DUBARD, MB ;
DAVIS, RO ;
ENTMAN, SS ;
IAMS, JD ;
CLIVER, SP .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (01) :78-84
[9]  
COTTON DB, 1984, J REPROD MED, V29, P92
[10]   EVALUATION OF RAPID DIAGNOSTIC-TESTS IN THE DETECTION OF MICROBIAL INVASION OF THE AMNIOTIC CAVITY [J].
COULTRIP, LL ;
GROSSMAN, JH .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 167 (05) :1231-1242